Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer
申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US10399933B2
公开(公告)日:2019-09-03
There are disclosed compounds of formula (I) that modulate or inhibit the enzymatic activity of indoleamine-2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.
INHIBITORS OF INDOLEAMINE-2,3-DIOXYGENASE FOR THE TREATMENT OF CANCER
申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20180072660A1
公开(公告)日:2018-03-15
There are disclosed compounds of formula (I) that modulate or inhibit the enzymatic activity of indoleamine-2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.
Direct sulfonylation of anilines mediated by visible light
作者:Tarn C. Johnson、Bryony L. Elbert、Alistair J. M. Farley、Timothy W. Gorman、Christophe Genicot、Bénédicte Lallemand、Patrick Pasau、Jakub Flasz、José L. Castro、Malcolm MacCoss、Darren J. Dixon、Robert S. Paton、Christopher J. Schofield、Martin D. Smith、Michael C. Willis
DOI:10.1039/c7sc03891g
日期:——
biologically active molecules and are key functional groups for organic synthesis. We report a mild, photoredox-catalyzed reaction for sulfonylation of aniline derivatives with sulfinate salts, and demonstrate the utility of the method by the late-stage functionalization of drugs. Key features of the method are the straightforward generation of sulfonyl radicals from bench-stable sulfinate salts and the